[Cardiotoxicity induced by 5-fluorouracil. A case report]

Area of Science:

• Oncology
• Cardiology
• Pharmacology

Background:

• 5-fluorouracil (5-FU) is a widely used chemotherapeutic agent for various cancers.
• Cardiotoxicity is a known, albeit uncommon, adverse effect associated with 5-FU treatment.
• Small intestine carcinoma is a relatively rare malignancy.

Observation:

• This report details a case of ischemic cardiopathy.
• The cardiac event occurred following the administration of 5-fluorouracil.
• The patient was being treated for carcinoma of the small intestine.

Findings:

• The observed ischemic cardiopathy is a potential adverse reaction to 5-fluorouracil.
• This suggests a possible link between 5-FU treatment and cardiac ischemia.
• The specific mechanism of 5-FU-induced cardiotoxicity warrants further investigation.

Implications:

• Awareness of potential cardiac side effects is crucial for clinicians managing patients on 5-FU.
• Cardiovascular monitoring may be considered in patients receiving 5-fluorouracil, especially those with pre-existing risk factors.
• Further research is needed to elucidate the incidence and pathophysiology of 5-FU-related ischemic cardiopathy.